White and Lewis \[[@ref1]\] comment on our article \[[@ref2]\] highlighting the methodological issues arising when attempting to use the National survey of Attitudes and Sexual Lifestyles (NATSAL) to calibrate estimates of seroprevalence derived from data available by sources such as the PHE Seroepidemiology Unit \[[@ref3]\] and Health Survey for England \[[@ref4]\]. White and Lewis \[[@ref1]\] do not challenge our observations. We agree with White and Lewis \[[@ref1]\] on the importance of data on health-seeking behaviour. It is not possible to use data on individuals who are tested for CT to make inferences about CT prevalence, or changes in CT prevalence over time, without information on how the CT prevalence relates to the probability of being tested, and how that changes over time \[[@ref5]--[@ref7]\]. Individuals may be tested for a number of reasons: following an *ad hoc* offer of opportunistic testing; as a result of symptoms; or concern about recent sexual encounters. Each of these factors may impact on CT prevalence among those tested in GP surgeries or GUM clinics.
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